novo nordisk glp-1 hikes full-year forecast on drug sales Novo Nordisk to close kidney

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach

Your healthcare provider or pharmacist will give you instructions on how and where to self-administer the injection

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects

start in minutes.

However, there was progress in the UK where the government announced Scotland CardioMetabolic Impact Study (SCoMIS) , a pioneering Real-World study, which will provide Wegovy to between 3,000-5,000 people living with Obesity in Scotlands poorest areas free of charge during a three year study [11] Despite FDA phasing out enforcement discretion that allowed GLP-1 compounding during shortages - and setting May 2025 deadlines for compounding to cease - compounding has continued beyond this deadline [12]

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated